Table 3.
Questionnaire and scales | Function(s) | Target population(s) | Advantages | Disadvantage(s) |
---|---|---|---|---|
Brief Medication Questionnaire | Patient's medication-taking behavior Barriers to adherence |
Diabetes Depression |
Self-administration Evaluate multidrug regimes Reduce practitioner's training |
Time-consuming |
| ||||
Hill-Bone Compliance Scale (Hill-Bone) | Patient's medication-taking behavior Barriers to adherence |
Hypertension specific, black patients | High internal consistency in both primary and outpatient setting | Limited generalizability |
| ||||
8-item Morisky Medication Adherence Scale (MMAS-8) | Patient's medication-taking behavior Barriers to adherence |
All validated conditions | Higher validity and reliability in patients with chronic diseases than MAQ | |
| ||||
Medication Adherence Questionnaire (MAQ) | Barriers to adherence | All validated conditions | Quickest to administer Validated in the broadest range of diseases Validated in patients with low literacy |
Comparatively short, mainly suitable for initial screening |
| ||||
The Self-Efficacy for Appropriate Medication Use Scale (SEAMS) | Barriers to adherence | All validated chronic conditions | High internal consistency in patients with high or low literacy | Time-consuming |
| ||||
Medication Adherence Report Scale (MARS) | Barriers to medication adherence Beliefs to medication adherence |
Chronic mental illness, especially with schizophrenia | Simplistic scoring Strong positive correlations compared to DAI and MAQ |
Limited generalizability |